featured
The Efficacy of Lapatinib Plus Trastuzumab in HER2-Positive Metastatic Breast Cancer Previously Treated With Trastuzumab, Lapatinib, or Both
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical & Translational Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Retrospective, Multicenter Study of the Efficacy of Lapatinib Plus Trastuzumab in HER2-Positive Metastatic Breast Cancer Patients Previously Treated With Trastuzumab, Lapatinib, or Both: The Trastyvere Study
Clin Transl Oncol 2019 Jun 15;[EPub Ahead of Print], J Gavilá, J De La Haba, B Bermejo, Á Rodríguez-Lescure, A Antón, E Ciruelos, J Brunet, E Muñoz-Couselo, M Santisteban, CA Rodríguez Sánchez, A Santaballa, P Sánchez Rovira, JÁ García Sáenz, M Ruiz-Borrego, AL Guerrero-Zotano, M Huerta, A Cotes-Sanchís, J Lao Romera, E Aguirre, J Cortés, A Llombart-CussacFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.